SCHEMBL25972721

SCHEMBL25972721

c1cc(-c2ccc3c4ccccc4n(-c4cc5ccccc5c5ccccc45)c3c2)c2c(-c3ccc4c5ccccc5n(-c5cc6ccccc6c6ccccc56)c4c3)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 4/20 0.37
TSHR P16473 3/20 0.37
MAPK1 P28482 3/20 0.37
HPGD P15428 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
CASP1 P29466 2/20 0.37
HIF1A Q16665 2/20 0.37
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.34
CASP7 P55210 1/20 0.34
ATM Q13315 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20149464 0.89 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL25972758 0.88 KDM4E (0.38) CYP1A2CYP2C9CYP2C19L3MBTL1ATM
SCHEMBL20149429 0.87 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL24526011 0.86 L3MBTL1 (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL780867 0.84 ALOX5 (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL20149453 0.84 L3MBTL1 (0.40) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL25671987 0.83 PDE6D (0.35) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL20149473 0.83 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL780864 0.83 ALOX5 (0.50) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL781013 0.83 ALOX5 (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250048-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-10 US disclosed
US-20230250048-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250048-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE NOS1, NOM1, NCF1 CYP1A2 1640/4885CYP2C9 596/4885CYP2C19 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.